相关实验视频
Updated: Jul 8, 2025

12:08
Diagonal Method to Measure Synergy Among Any Number of Drugs
Published on: June 21, 2018
18.6K
MOPDDI:基于多模式相互直角投影和多模式一致性损失的药物相互作用事件的预测
IEEE journal of biomedical and health informatics
|December 18, 2023
概括
准确预测药物相互作用 (DDI) 事件至关重要. 一种新方法使用多式直角投影和一致性损失来提高DDI预测的准确性,优于现有的方法.
科学领域:
- 药理学和化学信息学
- 人工智能在药物发现中的作用
背景情况:
- 准确预测药物相互作用 (DDI) 对安全有效的药物开发至关重要.
- 目前用于DDI预测的深度学习方法经常忽视多式联络药物数据中的冗余信息,并且缺乏跨模式特征的一致性.
研究的目的:
- 通过解决现有的深度学习方法的局限性,开发一种用于预测药物相互作用事件的新方法.
- 通过有效管理多式联络药物数据并确保不同数据类型的功能一致性,提高DDI预测的准确性.
主要方法:
- 拟议的方法采用多模式的相互直角投影模块来提取特征,消除了药物模式之间的冗余共信息.
- 调节间的一致性损失被用来强制执行不同药物模式的预测特征之间的相似性.
- 这种方法旨在提高DDI事件预测的稳定性和准确性.
主要成果:
- 这种新方法在已知的药物相互作用中实现了0.9500的预测准确度.
- 精度回忆曲线下的面积 (AUPR) 达到0.9833,表明性能优越.
- 对比实验表明,拟议的方法优于现有的最先进的DDI预测技术.
结论:
- 开发的方法有效地预测药物相互作用事件,具有高准确性和可靠性.
- 通过解决多式联运数据冗余和确保跨式联运一致性,该方法在DDI预测方面取得了重大进展.
- 这项工作为药物研发提供了宝贵的工具,有助于更安全的药物使用.
相关概念视频
Combined Effects of Drugs: Synergism
3.9K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
3.9K
Agonism and Antagonism: Quantification
377
When drugs are administered, they can elicit either an agonist or antagonist effect on the body. Agonism occurs when a drug activates a specific receptor, triggering a biological response. On the other hand, antagonism happens when a drug binds to the same receptors but blocks their activation, thereby preventing a biological response.
To quantify these effects, researchers use a dose-response curve, which provides valuable information about the potency and efficacy of a drug. Potency refers to...
To quantify these effects, researchers use a dose-response curve, which provides valuable information about the potency and efficacy of a drug. Potency refers to...
377
Combined Effects of Drugs: Antagonism
8.5K
The combined effects of drugs can result in various interactions, of which an important type is antagonism. Antagonism is a mechanism where one drug inhibits or counteracts the effects of another drug. Antagonism can occur through various means, including receptor binding, allosteric modulation, functional interaction, chemical reactions, and pharmacokinetic processes.
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
8.5K
Drug Concentration Versus Time Correlation
790
The plasma drug concentration-time curve is a crucial tool in pharmacokinetics, representing the drug's concentration in plasma at different time intervals post-administration. This curve illustrates the drug's journey from absorption into the systemic circulation, distribution to body tissues, and eventual elimination through excretion or biotransformation.
Two pivotal parameters are the minimum effective concentration (MEC) and the minimum toxic concentration (MTC). The MEC is the...
Two pivotal parameters are the minimum effective concentration (MEC) and the minimum toxic concentration (MTC). The MEC is the...
790
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models
71
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
71
Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis
66
Noncompartmental analyses offer an alternative method for describing drug pharmacokinetics without relying on a specific compartmental model. In this approach, the drug's pharmacokinetics are assumed to be linear, with the terminal phase log-linear. This assumption allows for simplified analysis and interpretation of the drug's behavior in the body.
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
66

